article thumbnail

Voyager licenses gene therapy tools to Novartis

Bio Pharma Dive

The Swiss drugmaker's decision is the latest in a string of partnership announcements for the gene therapy maker, which aims to bounce back from past research failures

article thumbnail

Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lava fires up a $700m cancer licensing deal with Seagen

Pharma Phorum

While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting on with its own business development, including a just-agreed licensing deal for a cancer immunotherapy developed by Dutch biotech Lava Therapeutics.

Licensing 111
article thumbnail

Merck pays $250M to license Moderna cancer vaccine

Bio Pharma Dive

The drugmaker’s decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release

Licensing 314
article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

The post Kite and Daiichi Sankyo update cell therapy licensing agreement appeared first on Pharmaceutical Technology. Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel).

Licensing 305
article thumbnail

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Licensing 246
article thumbnail

uniQure signs license deal for Apic Bio’s gene therapy for SOD1-ALS

Pharmaceutical Technology

Gene therapy company uniQure has entered into a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1).

article thumbnail

Novartis licenses cocaine use disorder therapy to Stalicla

Pharma Phorum

Swiss biotech Stalicla has continued to diversify its pipeline from a focus on autism therapies with a deal to license Novartis’ mavoglurant, in clinical trials for cocaine use disorder (CUD) as well as neurodevelopmental disorders (NDD).

article thumbnail

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

Fierce Pharma

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Licensing 145
article thumbnail

Gilead Sciences to exclusively license Nurix Therapeutics’ protein degrader

Pharmaceutical Technology

Gilead Sciences has exercised its option to exclusively license the investigational targeted protein degrader development candidate, NX‑0479, from clinical-stage biopharmaceutical company Nurix Therapeutics.

Licensing 130
article thumbnail

Alteogen signs global license deal with Sandoz

Pharmaceutical Technology

South Korean biotechnology company Alteogen has signed an exclusive license agreement with Swiss company Sandoz to develop and market biosimilar products that are enabled by the former’s Hybrozyme technology.

Licensing 130
article thumbnail

TherapeuticsMD and Mayne sign product licensing agreements

Pharmaceutical Technology

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. Additionally, TherapeuticsMD will grant Mayne the exclusive license to market Annovera in the US.

Licensing 130
article thumbnail

Biohaven licenses Hangzhou Highlightll’s BHV-8000 to treat brain disorders

Pharmaceutical Technology

Biohaven has purchased the exclusive global rights for oral, brain-penetrant dual Tyrosine Kinase 2 (TYK2)/Janus Kinase 1 (JAK1) inhibitor, BHV-8000 (previously TLL-041), which treats immune-mediated brain disorders , from Hangzhou Highlightll Pharmaceutical.

Licensing 130
article thumbnail

Astellas licenses companion drug for Pompe gene therapy

Pharma Phorum

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease. The post Astellas licenses companion drug for Pompe gene therapy appeared first on.

article thumbnail

Lantheus on POINT in radio-oncology with $2bn licensing deal

Pharma Phorum

Lantheus’ pipeline-building drive in radiopharma has continued with a $260 million upfront deal to license rights to two oncology candidates from POINT Biopharma. The post Lantheus on POINT in radio-oncology with $2bn licensing deal appeared first on.

article thumbnail

Merck agrees to license COVID-19 pill widely through pact with patent group

Bio Pharma Dive

The deal with the Medicines Patent Pool is meant to increase access in lower-income countries to molnupiravir, an experimental drug that could become the first oral treatment for COVID-19

Licensing 318
article thumbnail

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

Pharma Mirror

The post Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc appeared first on Pharma Mirror Magazine.

Licensing 130
article thumbnail

Takeda signs licensing agreement with HUTCHMED for fruquintinib

Pharmaceutical Technology

The post Takeda signs licensing agreement with HUTCHMED for fruquintinib appeared first on Pharmaceutical Technology. Takeda has signed an exclusive licence agreement with HUTCHMED (China) and its subsidiary HUTCHMED to develop and market the latter’s fruquintinib.

Licensing 130
article thumbnail

Sobi bolsters blood division via $435m ADC licensing deal

Pharma Phorum

Swedish rare disease specialist Sobi is paying $55 million upfront to license rights to ADC Therapeutics’ lymphoma therapy Zynlonta – approved in the US last year – in Europe and other international markets.

article thumbnail

How Different Crimes Can Affect Your Nursing License in Georgia

Pharma Mirror

But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.

Nurses 130
article thumbnail

Adcendo and Duality Biologics sign license deal for ADC platform

Pharmaceutical Technology

The post Adcendo and Duality Biologics sign license deal for ADC platform appeared first on Pharmaceutical Technology. Danish biotech company Adcendo has entered into a licence agreement with Duality Biologics on the next-generation antibody-drug conjugates (ADC) platform.

Licensing 130
article thumbnail

Roche deepens ties with Jnana with a second licensing deal

Pharma Phorum

The post Roche deepens ties with Jnana with a second licensing deal appeared first on.

Licensing 105
article thumbnail

NIH licenses COVID-19 technologies to WHO-backed program

Bio Pharma Dive

The agreement, which covers three experimental vaccines as well as several key patents, will be royalty free for products sold in 49 low-income countries

Licensing 150
article thumbnail

Shionogi and MPP enter Covid-19 antiviral licensing deal

Pharmaceutical Technology

The post Shionogi and MPP enter Covid-19 antiviral licensing deal appeared first on Pharmaceutical Technology.

Licensing 147
article thumbnail

Should e-cigarettes be licensed as medicines?

Scienmag

Latest News Ecigarettes licensed MedicinesNicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains. Yet a Cochrane review already supports existing e-cigarettes as a smoking cessation aid, as does recently updated guidance […].

article thumbnail

Purdue invention to improve health and welfare of farrowing sows is licensed to Canadian company

Scienmag

and WINNIPEG, Manitoba — A patented Purdue University invention designed to cool sows and lower their respiration rate while farrowing has been licensed to Innovative Heating Technologies for further beta testing and commercialization. WEST LAFAYETTE, Ind.,

article thumbnail

Harvard Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics to facilitate infectious and immune disease and cancer diagnostics

Scienmag

announced that the Institute’s electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Medicine & Health Antisoma cancer Diagnostics Disease eRapid facilitate Harvard immune infectious Institutes licensed sensor technology therapeutics Wyss

article thumbnail

Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal

BioSpace

Merck entered into a license and collaboration agreement with Chinese company Kelun-Biotech to develop seven antibody-drug conjugates candidates against oncology targets

article thumbnail

Melinta and Cidara sign licensing deal for rezafungin

Pharmaceutical Technology

The post Melinta and Cidara sign licensing deal for rezafungin appeared first on Pharmaceutical Technology. Melinta Therapeutics has signed a licence agreement with Cidara Therapeutics to facilitate a strategic collaboration for marketing the latter’s rezafungin in the US.

Licensing 147
article thumbnail

TherapeuticsMD lays off entire workforce after licensing products out for $153M

Fierce Pharma

TherapeuticsMD lays off entire workforce after licensing products out for $153M. zbecker. Thu, 12/08/2022 - 15:35

article thumbnail

Biogen licenses subcutaneous drug delivery system for neurological drugs

Outsourcing Pharma

Biogen partners with Alcyone to gain access to ThecaFlex, which is able to deliver therapies into the intrathecal space. Drug Delivery

article thumbnail

Licensing deal aimed at progressing cell and gene therapies in the treatment of rare diseases

BioPharma Reporter

Curamys, a South Korean biotech developing cell and gene therapy using cell fusion technology to treat rare intractable diseases, has signed a strategic platform licensing agreement with US tech developer, MaxCyte.

article thumbnail

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

article thumbnail

Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases

Scienmag

announce that the Wyss Institute’s affinity-based, multiplexed, electrochemical sensing technology, eRapid, has been licensed to the startup. The license, coordinated by Harvard’s Office of Technology Development (OTD), grants StataDX exclusive worldwide access to […].

article thumbnail

Akili adds to ADHD gaming range with £37m TALi licensing deal

Pharma Phorum

Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to add to its range via a licensing deal with Australia’s TALi Digital. .

article thumbnail

Ferrer and Asceneuron sign licensing agreement to develop PSP drug

Outsourcing Pharma

A licensing agreement has been signed that will give Spanish pharma company, Ferrer, worldwide rights to a treatment for progressive supranuclear palsy (PSP).

article thumbnail

Is License Compulsory For Starting Pharmaceutical Business In India?

Fossil Remedies

To launch the best PCD pharma franchise company, you will have to acquire the necessary licenses from authorities. The next important thing is the license. Every pharma company needs a drug license number to begin distribution, marketing, and manufacturing activities.

article thumbnail

Synaffix secures additional ADC technology licensing deals

BioPharma Reporter

Synaffix, a Netherlands based company providing clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), has signed off on two new licensing deals this week.

article thumbnail

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

article thumbnail

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Pharma Phorum

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The post Chinese tech giant Baidu licenses mRNA algorithm to Sanofi appeared first on.

Licensing 105
article thumbnail

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

Licensing 122
article thumbnail

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II

BioSpace

A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides

Licensing 110
article thumbnail

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

BioSpace

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day